TMCnet News

Zafgen to Present at the Wedbush PacGrow Healthcare Conference
[August 06, 2019]

Zafgen to Present at the Wedbush PacGrow Healthcare Conference


BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of metabolic diseases, announced today that Jeffrey Hatfield, Chief Executive Officer of Zafgen, Inc. is scheduled to present at the Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019, at 8:00 a.m. ET.

A live audio webcast and replay of the presentation will be available through the Events and Presentations page of the Investors section of the Company's website (www.zafgen.com

About Zafgen
Zafgen (Nasdaq:ZFGN) is a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by complex metabolic diseases. Zafgen has pioneered the study of MetAP2 inhibitors in both common and rare metabolic disorders. Learn more at
www.zafgen.com.

Media/Investor Relations Contacts:
Zafgen, Inc.
Patricia Allen
Chief Financial Officer
617-648-9792


Media
Krystle Gibbs
Ten Bridge Communications 
[email protected]
508-479-6358

Investors
John Woolford
Westwicke
[email protected]
443-213-0506

Primary Logo


[ Back To TMCnet.com's Homepage ]